Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
Classificação em ações #29910
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
Preço da ação
$1.10
Última sincronização: 2023-06-07
Valor de mercado
$19.12M
Variação (1 dia)
-0.90%
Variação (1 ano)
0.00%
País
US
Negociar Satsuma Pharmaceuticals, Inc. (STSA)

Categoria

Preço STSA com a capitalização de mercado de B
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
STSA
$1.10
Capitalização de mercado de Satsuma Pharmaceuticals, Inc.(STSA)
Valor de mercado: $19.12M
Em August 2026, Satsuma Pharmaceuticals, Inc. tem uma capitalização de mercado de $19.12M. Isso faz com que Satsuma Pharmaceuticals, Inc. seja a 29910th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Satsuma Pharmaceuticals, Inc. de 2019 a 2026
STSA comparado com o topo de 5 mais populares stocks
Preço para STSA Ativo B Capitalização de mercado de B Resultados
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$305,274 $19.12M
$5.307T +27,752,060.77%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$261,792 $19.12M
$4.551T +23,799,151.07%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$238,990 $19.12M
$4.154T +21,726,238.19%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$206,440 $19.12M
$3.589T +18,767,150.37%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$160,895 $19.12M
$2.797T +14,626,747.68%